NCT04038931View on ClinicalTrials.gov

Collection of Human Liver Biopsy and Whole Blood Samples From T1DM, TP or PP Patients for Potential Use for Insulin Producing Cells in Future Clinical Studies

UnknownOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

June 20, 2020

Study Completion Date

June 20, 2020

Conditions
Type 1 DiabetesPancreatectomy; Hyperglycemia
Interventions
OTHER

Liver biopsy collection

Liver biopsy collection to Confirm suitability of T1DM, total or partial pancreatectomy patient's liver cells to be used as future personalized cell replacement therapy.

Sponsors

Lead Sponsor

Orgenesis Ltd.
All Listed Sponsors
lead

Orgenesis Ltd.

INDUSTRY

NCT04038931 - Collection of Human Liver Biopsy and Whole Blood Samples From T1DM, TP or PP Patients for Potential Use for Insulin Producing Cells in Future Clinical Studies | Biotech Hunter | Biotech Hunter